CD4 and lung cancer: Concerning Treg again, Yin et al. reported that lung cancer cells deliver increased levels of miR-214 to CD4+ T cells through exosomes, allowing thus the decrease of PTEN levels and the expansion of CD4+ CD25high Foxp3+ Treg in a mouse model [33].